CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer
- PMID: 9010043
- PMCID: PMC2063260
- DOI: 10.1038/bjc.1997.50
CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer
Abstract
Sixty-three patients with extensive-stage small-cell lung cancer were randomized to receive either cyclophosphamide, vincristine, doxorubicin and etoposide (CODE) alone or CODE plus recombinant human granulocyte colony-stimulating factor (rhG-CSF). rhG-CSF administration in support of CODE chemotherapy resulted in increased mean total received dose intensity for all drugs (P = 0.03) with a significant improvement in survival (P = 0.004).
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
